Page last updated: 2024-08-18

4-butyrolactone and Coronary Disease

4-butyrolactone has been researched along with Coronary Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chan, AT; Franke, AA; Hu, FB; Hu, Y; Li, J; Li, Y; Liang, L; Liu, G; Mukamal, KJ; Rimm, EB; Sun, Q1
Alfthan, G; Ariniemi, K; Erlund, I; Kilkkinen, A; Virtamo, J; Virtanen, MJ1
Bonnet, F; Gilbert, R1
Adlercreutz, H; Kaikkonen, J; Morrow, JD; Nurmi, T; Roberts, LJ; Salonen, JT; Vanharanta, M; Voutilainen, S1

Trials

1 trial(s) available for 4-butyrolactone and Coronary Disease

ArticleYear
Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
    American journal of epidemiology, 2006, Apr-15, Volume: 163, Issue:8

    Topics: 4-Butyrolactone; Aged; alpha-Tocopherol; beta Carotene; Biomarkers; Case-Control Studies; Coronary Disease; Finland; Humans; Lignans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Smoking

2006

Other Studies

3 other study(ies) available for 4-butyrolactone and Coronary Disease

ArticleYear
Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
    The American journal of clinical nutrition, 2021, 07-01, Volume: 114, Issue:1

    Topics: 4-Butyrolactone; Adult; Case-Control Studies; Coronary Disease; Diet; Female; Gastrointestinal Microbiome; Humans; Lignans; Male; Methylamines; Prospective Studies; Risk Factors; United States

2021
Enterolactone and coronary events.
    Lancet (London, England), 2000, May-06, Volume: 355, Issue:9215

    Topics: 4-Butyrolactone; Coronary Disease; Diabetes Mellitus; Estrogens; Humans; Lignans; Risk Assessment

2000
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.
    Atherosclerosis, 2002, Volume: 160, Issue:2

    Topics: 4-Butyrolactone; Coronary Disease; Estrogens; F2-Isoprostanes; Homocysteine; Humans; Lignans; Lipid Peroxidation; Male; Middle Aged; Multivariate Analysis; Risk Factors

2002